Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative Oxybutynin for Opioid-Sparing in Pediatric Urologic Reconstruction
NCT07911137Phase 4Not yet recruiting
- Sponsor
- University of Calgary
- Start
- Nov 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 4 trial of oxybutynin in bladder spasms, sponsored by University of Calgary. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
oxybutynin
03
Conditions
bladder spasms
Beyond the preview
Go deeper on NCT07911137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07911137.